Eternity in Medical Information -- Medisurf
Items 1 ~ 8 of 286, Page 1 of 36
Statement from Jeffrey Shuren, M.D., J.D., Director of the FDA’s Center for Devices and Radiological Health, on new steps to help reduce risks associated with surgical staplers for internal use and implantable staples
04.23.2019 U.S. FOOD & DRUG ADMINISTRATION
FDA provides update on its ongoing investigation into ARB drug products; reports on finding of a new nitrosamine impurity in certain lots of losartan and product recall
The U.S. Food and Drug Administration is updating the public on the agency’s ongoing investigation surrounding the recent voluntary recalls of multipl...
03.01.2019 U.S. FOOD & DRUG ADMINISTRATION
Statement from FDA Commissioner and director of the Center for Drug Evaluation and Research on the FDA’s ongoing investigation into valsartan and ARB class impurities and the agency’s steps to address the root causes of the safety issues
01.25.2019 U.S. FOOD & DRUG ADMINISTRATION
FDA statement from Commissioner announcing efforts to improve the quality of the information used to assess the effectiveness of REMS programs in supporting the safe use of medications
Risk Evaluation and Mitigation Strategy (REMS)
01.24.2019 U.S. FOOD & DRUG ADMINISTRATION
FDA warns API manufacturer involved in valsartan recall, provides information for patients taking these medications
12.11.2018 U.S. FOOD & DRUG ADMINISTRATION
Statement from FDA Commissioner Scott Gottlieb, M.D. and Jeff Shuren, M.D., Director of the Center for Devices and Radiological Health, on transformative new steps to modernize FDA’s 510(k) program to advance the review of the safety and effectiveness of medical devices
Modernizing the 510(k) Pathway“Safety and Performance Based Pathway” / Promoting Greater Transparency and Post-Market Surveillance
11.26.2018 U.S. FOOD & DRUG ADMINISTRATION
Statement by FDA Commissioner Scott Gottlieb, M.D., on the FDA’s efforts to hold industry accountable for fulfilling critical post-marketing studies of the benefits, safety of new drugs
11.16.2018 U.S. FOOD & DRUG ADMINISTRATION
China hides identities of top scientific recruits amidst growing US scrutiny
Chinese researchers fear that affiliation with the high-status Thousand Talents scheme could make them targets of FBI investigations.
10.24.2018 Nature News by Smriti Mallapaty
   
1 2 3 4 5 6 7 8 9 10